Gerard Mazon

Gerard Mazon currently serves as the Principal Investigator at Gustave Roussy, one of Europe's leading cancer research and treatment centers, where he directs an independent research group within the CNRS unit 9019 "Genetic Integrity and Cancers." His team focuses on elucidating the molecular mechanisms underlying DNA double-strand break (DSB) repair and their critical role in maintaining genome stability, a fundamental aspect of cancer biology. Leveraging advanced techniques in molecular biology, genetics, and biochemistry, Gerard's research aims to uncover how defects in DNA repair pathways contribute to tumorigenesis and resistance to therapy.

At Gustave Roussy, Gerard is actively involved in key projects that integrate cutting-edge assay development, protein expression analysis, and flow cytometry to dissect the complex interactions involved in DNA recombination and repair processes. His expertise in molecular cloning, RT-PCR, and RNA isolation enables his team to identify novel genetic factors influencing genome integrity. Additionally, Gerard collaborates with multidisciplinary teams to translate fundamental insights into potential therapeutic strategies, such as targeting DNA repair pathways to sensitize cancer cells to radiotherapy and chemotherapy.

His leadership at Gustave Roussy not only advances our understanding of cancer etiology but also fosters innovative approaches in precision medicine. By combining his extensive background in protein expression, immunofluorescence, and biochemistry, Gerard Mazon continues to contribute significantly to the development of targeted interventions that aim to improve patient outcomes through a deeper understanding of DNA repair mechanisms in cancer.